Study summary · 2024 · Evidence review

Heart-failure telehealth: pooled benefits and mixed studies

Pooled one-year outcomes favored monitoring, but narrative findings were mixed and the review combines different designs and technologies.

Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence

Original publication

Telehealth care and remote monitoring strategies in heart failure patients: A systematic review and meta-analysis

Vittorio Masotta; Angelo Dante; Valeria Caponnetto; Alessia Marcotullio; Fabio Ferraiuolo; Luca Bertocchi; Francesco Camero; Loreto Lancia; Cristina Petrucci

University of L’Aquila, Italy

Heart & Lung · Online: · Issue: March 2024

Journal version of record. · Full text consulted.

What was studied

Design
Evidence review
Population
Heart-failure populations across NYHA classes
Sample
61 studies; 17 contributed to meta-analyses
Intervention
Mixed telemonitoring, telephone support and implanted-device monitoring
Comparator
Usual care
Follow-up
One-year pooled endpoints; variable follow-up in narrative synthesis
Review search cutoff
2021-08
Setting
Multiple countries

Methods

Random-effects meta-analyses combined eligible randomized and observational studies. The search predates publication by more than two years.

Findings

One-year mortality OR was 0.54 (95% CI 0.39–0.76; I² 56.39%); rehospitalization OR was 0.56 (0.40–0.80; I² 77.79%). The broader narrative synthesis did not show consistent rehospitalization benefit.

Limitations

High heterogeneity, observational confounding, language restrictions and an unregistered protocol limit certainty. Subgroup comparisons do not isolate causal program components. Trials overlap with other heart-failure reviews.

What this means for care delivery

These odds ratios are not relative risk reductions. Interpret the favorable pooled subset alongside the mixed narrative evidence, rather than applying its average effect to every RPM service.